Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating safety and efficacy of TD-1211 for opioid-induced constipation in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• TD-1211

Snippet

Sponsor: Theravance Biopharma | Conditions: Opioid Induced Constipation | Phase 2 | Status: COMPLETED